Citations are updated once a week. Recently added citations may not appear.
Context | Citation |
---|---|
lactobacillus brevis (probiotics) |
?
Effect of Lactobacillus brevis CD2 containing lozenges and plaque pH and cariogenic bacteria in diabetic children: a randomised clinical trial. Clinical oral investigations (Clin Oral Investig ) Vol: 25 Issue 1 Pages: 115-123 Pub: 2021 Jan Epub: 2020 Oct 21 Authors Lai S , Lingström P , Cagetti MG , Cocco F , Meloni G , Arrica MA , Campus G , Html Article Publication |
lactobacillus brevis (probiotics) |
?
<i>Lactobacillus brevis</i> Alleviates DSS-Induced Colitis by Reprograming Intestinal Microbiota and Influencing Serum Metabolome in Murine Model. Frontiers in physiology (Front Physiol ) Vol: 10 Issue Pages: 1152 Pub: 2019 Epub: 2019 Sep 18 Authors Ding S , Ma Y , Liu G , Yan W , Jiang H , Fang J , Html Article Publication |
lactobacillus brevis (probiotics) |
?
The effect of Lactobacillus brevis KB290 against irritable bowel syndrome: a placebo-controlled double-blind crossover trial. BioPsychoSocial medicine (Biopsychosoc Med ) Vol: 6 Issue 1 Pages: 16 Pub: 2012 Aug 3 Epub: 2012 Aug 3 Authors Murakami K , Habukawa C , Nobuta Y , Moriguchi N , Takemura T , Html Article Publication |
lactobacillus brevis (probiotics) |
?
Estimating modifiers from bacteria associations Microbiome Prescription (Lassesen Consulting, LLC ) Vol: 2023 Issue 3 Pages: 3342-3347 Pub: 2023 Apr Epub: Authors K Lassesen , Publication |
lactobacillus brevis (probiotics) |
?
Lactobacillus brevis CD2 inhibits Prevotella melaninogenica biofilm. Oral diseases (Oral Dis ) Vol: 20 Issue 7 Pages: 668-74 Pub: 2014 Oct Epub: 2013 Oct 31 Authors Vuotto C , Barbanti F , Mastrantonio P , Donelli G , Publication |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.